• Waqtola Cheneke Jimma University, Institute of Health, Faculty of Health Sciences, School of Medical Laboratory Sciences, Ethiopia
  • Berhanu Sufa Department of Medical Laboratory Science, Harar Health Science College, Harar, East Ethiopia



Prevalence, Metabolic Syndrome, Hormonal Contraceptives, Risk Factor, Ethiopia

Abstract [English]

Background:  Metabolic syndrome is associated with the risk of developing cardiovascular disease and type 2 diabetes. Cardiovascular disease is among the most cause of death in non-communicable diseases. The use of contraceptive is incriminated to increase the risk of cardiovascular diseases and metabolic syndrome. However, there is no clear evidence and metabolic syndrome among contraceptive users is not well described. This study is therefore focused to determine the prevalence of metabolic syndrome among contraceptive users in Harar.

Methods: A facility based cross sectional study was conducted from April – June 2014 to determine the prevalence of metabolic syndrome and associated factors in Harar town. 365 hormonal contraceptive users from three health centers and one hospital were consecutively included in the study. Socio-demographic data and anthropometric measurements were obtained. Venous blood was drawn from each study subjects and lipid profile and fasting serum glucose were measured photometrically. Prevalence of metabolic syndrome was determined using descriptive statistics and logistic regression analysis with 95% CI using statistical package for social science (SPSS, version 20 for windows).

Result: The overall prevalence of metabolic syndrome was found to be 27.7%.  Metabolic syndrome was found about 9 times more likely among women with age ≥40 years than those with age <20 years (Odds Ratio (OR) 8.571; 95% CI 1.004, 73.210, p = 0.050); about 2 times more likely among those with income >1,500 Ethiopian birr (ETB) than those with those <1,500 ETB (OR 1.637, 95% CI 1.032-2.599, p = 0.036) and about 6 times more likely among those who used hormonal contraceptive for more than 42 weeks than those who used it for 6-17.9 weeks (OR 5.897, 95% CI 2.924-11.891, p = 0.000)

Conclusion: This study revealed that metabolic syndrome is high among contraceptive users and higher than the rate of metabolic syndrome among community and other healthy working population. Contraceptive users with older age, with higher income and those who used the drug for longer time were found to have more metabolic syndrome than their counter parts.


Download data is not yet available.


WHO. Cardiovascular diseases (VDs) Key facts; 17 May 2017. Accessed on 20 July 2019.

WHO. Noncommunicable diseases (NCD) Key facts; 1 June 2018. Accessed on 20 July 2019.

Kaur J. A comprehensive review on metabolic syndrome [retracted in: Cardiol Res Pract. 2019 Jan 31;2019:4301528]. Cardiol Res Pract. 2014;2014:943162. doi:10.1155/2014/943162 DOI:

Felizola, Saulo JA. Ursolic acid in experimental models and human subjects: Potential as an anti-obesity/overweight treatment?. 2015; doi:10.13140/RG.2.1.4502.4804

Falkner B, Cossrow ND. Prevalence of metabolic syndrome and obesity-associated hypertension in the racial ethnic minorities of the United States. Current Hypertension Reports. 2014; 16 (7): 449. doi:10.1007/s11906-014-0449-5. PMC 4083846. PMID 24819559 DOI:

Beltrán-Sánchez H, Harhay MO, Harhay MM, McElligott S. Prevalence and trends of metabolic syndrome in the adult U.S. population, 1999–2010. Journal of the American College of Cardiology. 2013; 62 (8): 697

doi:10.1016/j.jacc.2013.05.064. PMC 3756561. PMID 23810877 DOI:

Abda E, Hamza L, Tessema F, Cheneke W. Metabolic syndrome and associated factors among outpatients of Jimma University Teaching Hospital. Diabetes Metab Syndr Obes. 2016;9:47–53. Published 2016 Mar 4. doi:10.2147/DMSO.S97561 DOI:

Bosho DD, Dube L, Mega TA, Adare DA, Tesfaye MG, Eshetie TC. Prevalence and predictors of metabolic syndrome among people living with human immunodeficiency virus (PLWHIV). Diabetol Metab Syndr. 2018;10:10. Published 2018 Feb 21. doi:10.1186/s13098-018-0312-y DOI:

Asaye S, Bekele S, Tolessa D, Cheneke W. Metabolic syndrome and associated factors among psychiatric patients in Jimma University Specialized Hospital, South West Ethiopia. Diabetes Metab Syndr. 2018 Sep;12(5):753-760. doi: 10.1016/j.dsx.2018.04.037. Epub 2018 Apr 24. DOI:

Woyesa SB, Hirigo AT, Wube TB. Hyperuricemia and metabolic syndrome in type 2 diabetes mellitus patients at Hawassa university comprehensive specialized hospital, South West Ethiopia. BMC Endocr Disord. 2017;17(1):76. Published 2017 Dec 12. doi:10.1186/s12902-017-0226-y DOI:

Tran, B. Gelaye, B. Girma, et al., Prevalence of Metabolic Syndrome among Working Adults in Ethiopia, International Journal of Hypertension, vol. 2011, Article ID 193719, 8 pages, 2011. DOI:

Wiegratz I, Thaler CJ. Hormonal contraception--what kind, when, and for whom?. Dtsch Arztebl Int. 2011;108(28-29):495–506. doi:10.3238/arztebl.2011.0495 DOI:

Jamil S, Siddiq A. Comparison of CVD risk associated with the long term use of contraceptives in young females. J Appl Pharm Sci. 2012;2(11):062–6.

Kerie S, Menberu M, Geneto M. Metabolic syndrome among residents of Mizan-Aman town, South West Ethiopia, 2017: A cross sectional study. PLoS One. 2019;14(1):e0210969. Published 2019 Jan 31. doi:10.1371/journal.pone.0210969 DOI:

Birarra MK, Gelayee DA. Metabolic syndrome among type 2 diabetic patients in Ethiopia: a cross-sectional study. BMC Cardiovasc Disord. 2018;18(1):149. Published 2018 Jul 17. doi:10.1186/s12872-018-0880-7 DOI:

Biadgo B, Melak T, Ambachew S, et al. The Prevalence of Metabolic Syndrome and Its Components among Type 2 Diabetes Mellitus Patients at a Tertiary Hospital, Northwest Ethiopia. Ethiop J Health Sci. 2018;28(5):645–654. doi:10.4314/ejhs.v28i5.16

Tachebele B, Abebe M, Addis Z, Mesfin N. Metabolic syndrome among hypertensive patients at University of Gondar Hospital, North West Ethiopia: a cross sectional study. BMC Cardiovasc Disord. 2014;14:177. Published 2014 Dec 6. doi:10.1186/1471-2261-14-177 DOI:

Tadewos A, Egeno T, Amsalu A. Risk factors of metabolic syndrome among hypertensive patients at Hawassa University Comprehensive Specialized Hospital, Southern Ethiopia. BMC Cardiovasc Disord. 2017;17(1):218. Published 2017 Aug 8. doi:10.1186/s12872-017-0648-5 DOI:

Sufa B, Abebe G, Cheneke W. Dyslipidemia and associated factors among women using hormonal contraceptives in Harar town, Eastern Ethiopia. BMC Res Notes. 2019;12(1):120. Published 2019 Mar 4. doi:10.1186/s13104-019-4148-9 DOI:




How to Cite